2018 Press Releases

Webcast ImageWebcast
Q3 2018 NantHealth Earnings Conference Call (Live)
11/15/18 at 4:30 p.m. ET
Q3 2018 NantHealth Earnings Conference Call
Thursday, November 15, 2018 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
DateTitle 
11/07/18NantHealth®, B. Braun Australia, GE Healthcare and iProcedures Join Forces to Bridge Connectivity Gap Between Patient Devices, Data and Medical Records at the Healthcare Information and Management Systems Society (HIMSS) Asia Pacific Conference
NantHealth demonstrates new DeviceConX™ features including enterprise support for larger health systems and high fidelity waveform capture BRISBANE, Australia & CULVER CITY, Calif.--(BUSINESS WIRE)--Nov. 7, 2018-- NantHealth (NASDAQ: NH), a leader in breakthrough cancer research and solutions to improve patient care and lower healthcare costs, today announced a collaboration with B. Braun Australia, GE Healthcare and iProcedures to demonst... 
Printer Friendly Version
11/07/18NantHealth® Advances Clinician Productivity and Critical Patient Information Access with Enhancements to DeviceConX™
New DeviceConX Enhancements Showcased at the Healthcare Information and Management Systems Society (HIMSS) Interoperability Showcase™ Asia Pacific Conference and Exhibition Featuring NantHealth, B. Braun Australia, GE Healthcare, and iProcedures BRISBANE, Australia & CULVER CITY, Calif.--(BUSINESS WIRE)--Nov. 7, 2018-- NantHealth (NASDAQ: NH), a leader in breakthrough cancer research and data solutions that improve patient care and... 
Printer Friendly Version
11/07/18NantHealth to Report 2018 Third-Quarter Financial Results and Host Conference Call on Thursday, November 15
--Slight Delay in Reporting Financial Results, Due to Effects of Hurricane Michael-- CULVER CITY, Calif.--(BUSINESS WIRE)--Nov. 7, 2018-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2018 third quarter on Thursday, November 15, 2018, after market close. NantHealth management will host a conference call that same day at 1:30 p.... 
Printer Friendly Version
10/29/18NantHealth and NantOmics Present Four Research Papers Demonstrating Advancements in Cancer Diagnostics with NantHealth’s GPS Cancer® and Liquid GPS™
NantHealth’s Liquid GPS™ technology shows promise in the monitoring of key biomarkers in metastatic colorectal cancer MUNICH & CULVER CITY, Calif.--(BUSINESS WIRE)--Oct. 29, 2018-- Significant developments in cancer research were presented by NantHealth (NASDAQ: NH) and NantOmics at the ESMO conference in Munich, Germany this week. NantHealth, a leader in breakthrough cancer research and solutions to improve patient care and lower healthc... 
Printer Friendly Version
09/07/18NantHealth Announces Appointment of Two Senior Executives to Lead Strategy, Business Development, and Global Sales
Nikko Khazana and Mark Mozley will help drive growth of NantHealth’s portfolio, including GPS Cancer® and Liquid GPS products CULVER CITY, Calif.--(BUSINESS WIRE)--Sep. 7, 2018-- NantHealth, Inc., (NASDAQ: NH), a leading next-generation, evidence-based, personalized healthcare company, announced new executive appointments to lead the company’s strategy and business development as well as global sales. Nikko Khazana will serve as... 
Printer Friendly Version
08/09/18NantHealth Reports 2018 Second-Quarter Financial Results
Liquid GPS® Successfully Launched in Q2 Total Revenue in Q2 was $22.0 Million Revenue in 2017 Q2 included a large completed Connected Care device implementation of approximately $4 million, benefiting prior period revenue of $23.5 million SaaS revenue of $16.2 million in Q2, up 9% from $14.9 million in prior year Q2 In June... 
Printer Friendly Version
08/03/18NantHealth to Report 2018 Second-Quarter Financial Results and Host Conference Call on Thursday, August 9
CULVER CITY, Calif.--(BUSINESS WIRE)--Aug. 3, 2018-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2018 second quarter on Thursday, August 9, 2018, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance. The conference call will ... 
Printer Friendly Version
06/20/18NantHealth Unveils New Collaboration Tools - Provider Initiated Document Exchange and Authorization Appeals
Further Enhancing NaviNet Open’s Ability to Tackle Payer-Provider Communication Challenges LOS ANGELES--(BUSINESS WIRE)--Jun. 20, 2018-- NantHealth, Inc. (NASDAQ: NH) announced two exciting new product launches - Provider Initiated Document Exchange and Authorization Appeals - on the nation’s leading payer-provider collaboration platform, NaviNet® Open, at the 2018 AHIP Institute and Expo. Today, the exchange of information betw... 
Printer Friendly Version
06/19/18NantHealth to Present and Exhibit on the Convergence of Precision Medicine and Value-Based Care at America’s Health Insurance Plans (AHIP) Institute & Expo 2018
CULVER CITY, Calif. & SAN DIEGO--(BUSINESS WIRE)--Jun. 19, 2018-- NantHealth (NASDAQ: NH), a next-generation healthcare company, will exhibit and present at America’s Health Insurance Plans (AHIP) Institute & Expo 2018 taking place June 20-22, 2018 at the San Diego Convention Center in San Diego, CA at booth #824. NantHealth, a Silver-Sponsor at the AHIP Institute & Expo 2018, will showcase its health IT and precision medicine ... 
Printer Friendly Version
06/02/18NantHealth and NantOmics to Present Data on the Frequency of Non-Expressed Variants Tested by Standard NGS Panel at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting
Results to be presented during the tumor biology session at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting CHICAGO--(BUSINESS WIRE)--Jun. 2, 2018-- NantWorks, LLC today announced that its affiliate companies, NantHealth, Inc., (NASDAQ: NH), a leading next-generation, evidence-based, personalized healthcare company and NantOmics, LLC, the leader in molecular analysis and a member of the NantWorks ecosystem of compan... 
Printer Friendly Version
06/02/18NantHealth and NantOmics to Present Patterns of Immune Checkpoint Molecules in Relation to PD-L1 Expression at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting
Results to be presented during the tumor biology session at the ASCO 2018 Annual Meeting CHICAGO--(BUSINESS WIRE)--Jun. 2, 2018-- NantWorks, LLC today announced that its affiliate companies, NantHealth, Inc., (NASDAQ: NH), a leading next-generation, evidence-based, personalized healthcare company and NantOmics, LLC, the leader in molecular analysis and a member of the NantWorks ecosystem of companies, will present findings on how target... 
Printer Friendly Version
06/02/18NantHealth and NantOmics to Present Data on Three-Fold Overestimation of Tumor Mutation Burden Using Gene Panel vs Whole Exome at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting
Results to be presented during the tumor biology session at the ASCO 2018 Annual Meeting CHICAGO--(BUSINESS WIRE)--Jun. 2, 2018-- NantWorks, LLC today announced that its affiliate companies, NantHealth, Inc., (NASDAQ: NH), a leading next-generation, evidence-based, personalized healthcare company and NantOmics, LLC, the leader in molecular analysis and a member of the NantWorks ecosystem of companies, the leader in molecular diagnostics... 
Printer Friendly Version
06/02/18NantHealth and NantOmics to Share Data on Next-Generation Sequencing of Paired DNA and RNA Analysis of Rare Tumors at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting
Results to be presented during the tumor biology session at the ASCO 2018 Annual Meeting CHICAGO--(BUSINESS WIRE)--Jun. 2, 2018-- NantWorks, LLC today announced that its affiliate companies, NantHealth, Inc., (NASDAQ: NH), a leading next-generation, evidence-based, personalized healthcare company and NantOmics, LLC, the leader in molecular analysis and a member of the NantWorks ecosystem of companies, will present data on next-generatio... 
Printer Friendly Version
06/02/18NantHealth Unveils Liquid GPS™, Powerful Next-Generation Tool for Blood-Based Tumor Profiling and Quantitative Monitoring
Molecular test allows for continuous, noninvasive monitoring and tumor profiling CHICAGO--(BUSINESS WIRE)--Jun. 2, 2018-- NantHealth, Inc. (NASDAQ: NH), a leading next-generation, evidence-based, personalized healthcare company, unveiled Liquid GPS™ a powerful next-generation tool for blood-based tumor profiling and quantitative monitoring. NantHealth chose the American Society of Clinical Oncology (ASCO) 2018 Annual Meet... 
Printer Friendly Version
05/30/18NantHealth to Present at the Jefferies 2018 Global Healthcare Conference on June 6
CULVER CITY, Calif.--(BUSINESS WIRE)--May 30, 2018-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that its management will be presenting at the Jefferies 2018 Global Healthcare Conference on Wednesday, June 6, 2018, at 4 p.m. ET in New York City. A webcast of the presentation will be available at www.nanthealth.com. Listeners are encouraged to visit the web site at least 10 ... 
Printer Friendly Version
05/17/18NantHealth to Present at the Bank of America Merrill Lynch Health Care Conference 2018 on May 17
CULVER CITY, Calif.--(BUSINESS WIRE)--May 17, 2018-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that its management will be presenting at the Bank of America Merrill Lynch 2018 Health Care Conference on Thursday, May 17, 2018, at 11:20 a.m. PT in Las Vegas. About NantHealth, Inc. NantHealth, Inc., a member of the NantWorks ecosystem of companies, is a next-g... 
Printer Friendly Version
05/14/18NantHealth Showcases and Presents Its Portfolio of Medical Device Integration (MDI) Products to Provide Current and Future Insights to Patient Care at the Largest E-Health Event in Scandinavia
NantHealth’s Connected Care Solutions Announces International Growth at Vitalis 2018 with HCO Deployment in Sweden CULVER CITY, Calif.--(BUSINESS WIRE)--May 14, 2018-- NantHealth (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, showcased their Connected Care solutions at Vitalis, the largest e-health event in Scandinavia. The conference took place on April 24-26 at the Swedish Exhibition and Congress Centre in ... 
Printer Friendly Version
05/09/18CORRECTING and REPLACING NantHealth Reports 2018 First-Quarter Financial Results
Total Q1 Revenue of $22.3 Million, Up 17% from $19.1 Million in Prior Year Q1 SAAS Revenue of $16.2 Million in Q1, Up 9% from $14.8 Million in Prior Year Q1 Total Gross Margin increased to 50% in Q1, Up from 40% in Prior Year Q1 Study Results Demonstrating Benefits of Performing Tumor/Normal DNA and RNA Sequencing Published in Peer-Reviewed Medical Journal, Oncotarget ... 
Printer Friendly Version
05/09/18NantHealth Reports 2018 First-Quarter Financial Results
Total Q1 Revenue of $22.3 Million, Up 17% from $19.1 Million in Prior Year Q1 SAAS Revenue of $16.2 Million in Q1, Up 9% from $14.8 Million in Prior Year Q1 Total Gross Margin increased to 50% in Q1, Up from 40% in Prior Year Q1 Study Results Demonstrating Benefits of Performing Tumor/Normal DNA and RNA Sequencing Published in Peer-Reviewed Medical Journal, Oncotarget ... 
Printer Friendly Version
05/07/18NantHealth and NantOmics Announce Publication of Study Highlighting High Error Rates in Tumor-Only Sequencing for Cancer Treatment
Research shows approach that includes sequencing both normal genomes and tumor genomes increases accuracy and precision CULVER CITY, Calif.--(BUSINESS WIRE)--May 7, 2018-- NantHealth, Inc., (NASDAQ: NH), a leading next-generation, evidence-based, personalized healthcare company, and NantOmics, LLC, the leader in molecular diagnostics and a member of the NantWorks ecosystem of families, announced today joint results that show significant... 
Printer Friendly Version
05/04/18NantHealth to Report 2018 First-Quarter Financial Results and Host Conference Call on Wednesday, May 9
CULVER CITY, Calif.--(BUSINESS WIRE)--May 4, 2018-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2018 first quarter on Wednesday, May 9, 2018, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance. The conference call will be a... 
Printer Friendly Version
03/14/18NantHealth Reports 2017 Fourth-Quarter and Full-Year Financial Results
Total Q4 Revenue of $22.3 Million, Up 25% from $17.8 Million in Prior Year Q4 SAAS Revenue of $15.8 Million in Q4, Up 10% from $14.4 Million in Prior Year Q4 Total Gross Margin increased to 60% in Q4, Up from 39% in Prior Year Q4 Restructuring Plan and Sale of Provider/Patient Engagement Solutions Business Combined to Reduce Operating Loss by Nearly 53% in Q4 from Prior Year Q4... 
Printer Friendly Version
03/09/18NantHealth to Report 2017 Fourth-Quarter and Full-Year Financial Results and Host Conference Call on Wednesday, March 14
CULVER CITY, Calif.--(BUSINESS WIRE)--Mar. 9, 2018-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2017 fourth quarter and full year on Wednesday, March 14, 2018, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance. The confer... 
Printer Friendly Version
03/05/18NantHealth to Present on the Future of Device Connectivity across the Continuum of Care at HIMSS18
NantHealth will be exhibiting its Connected Care solutions at booth #14003 CULVER CITY, Calif. & LAS VEGAS--(BUSINESS WIRE)--Mar. 5, 2018-- NantHealth (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, will be exhibiting this year at the Healthcare Information & Management Systems Society Annual Conference & Exhibition 2018 (HIMSS18) taking place March 5-9 at the Venetian – Palazzo – Sands Expo Center... 
Printer Friendly Version
01/11/18Dr. Patrick Soon-Shiong Presents at the 36th Annual J.P. Morgan Healthcare Conference
Download Presentation (PDF)To watch the WebcastTo Listen to the Webcast... 
Printer Friendly Version
01/05/18Nantworks To Present Healthcare And Biotechnology Platforms At 36th Annual J.P. Morgan Healthcare Conference On January 9, 2018 In San Francisco, CA
Announces a Record 25 Letters of Authorization to Proceed with Clinical Trials Covering 12 Novel Biological Molecules in 20 Tumor Types January 5, 2018 — Culver City, California — NantWorks, the parent organization of NantHealth (NASDAQ: NH) and NantKwest (NASDAQ: NK) announced today that Dr. Patrick Soon-Shiong (Chairman, CEO, and Founder) will present the current status of these companies and the overall ecosystem of NantWorks. Specific details will be presented regarding the current status of... 
Printer Friendly Version